2016
DOI: 10.1016/j.radonc.2015.12.021
|View full text |Cite
|
Sign up to set email alerts
|

A pre-treatment quality assurance survey on 384 patients treated with helical intensity-modulated radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
12
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 9 publications
0
12
0
Order By: Relevance
“…TPS dose calculation (beam modeling, MLC modeling, commissioning inaccuracies) and MLC performance are also some potential sources of errors.The impact of HT plan parameters on the pretreatment QA results has already been investigated by other authors 2,8,9. Westerly et al,2 for instance, found that plans with a mean LOT below 100 ms, that is, using predominantly small leaf open times, were more likely to present significant deviations (>3%) between the calculated and the measured doses, in an analysis of six plans treated in a Tomotherapy Hi-Art II system.…”
mentioning
confidence: 93%
See 2 more Smart Citations
“…TPS dose calculation (beam modeling, MLC modeling, commissioning inaccuracies) and MLC performance are also some potential sources of errors.The impact of HT plan parameters on the pretreatment QA results has already been investigated by other authors 2,8,9. Westerly et al,2 for instance, found that plans with a mean LOT below 100 ms, that is, using predominantly small leaf open times, were more likely to present significant deviations (>3%) between the calculated and the measured doses, in an analysis of six plans treated in a Tomotherapy Hi-Art II system.…”
mentioning
confidence: 93%
“…2,7 More comprehensive studies for different treatment sites, including a wider set of TPS reported parameters, such as the couch travel, couch speed, number of gantry rotations, gantry period and treatment time, have been carried out. 8,9 Bresciani et al, 8 using 384 HT plans of multiple treatment sites, found no strong correlations between some of these factors and the results of pretreatment QA verification. Binny et al 9 have used multiple statistical process control methods on a set of head and neck (28), pelvic (19) and brain (23) plans, to define lower and upper limits for planning parameters, like the modulation factor, gantry period, and couch speed, based on acceptable pretreatment QA results.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The results here reportedly outperformed those obtained with different versions of tomotherapy machines and the same 3D dosimeter (ArcCHECK™) in terms of GP%. We measured systematically higher mean values with respect to Bresciani [7], Binny [9] and Yue [10]: 99.2% (SD 1.3%) vs 96.1% (SD 4.4%), 95.9%(SD 2.9%) and 97.5% (SD 2.7%), respectively.…”
Section: Discussionmentioning
confidence: 68%
“…In this work, we assessed the performances of the TomoTherapy® platform coupled with a new dedicated TPS in terms of the gamma index passing rate measured with a 3D dosimeter, extending the analysis of previous works on earlier versions of TomoTherapy® and associated TPS [7,8]. The entire scope of work was performed following AAPM TG-218 recommendations.…”
Section: Discussionmentioning
confidence: 99%